Description

Metformin Tablet

Metformin Hydrochloride Sustained-Release (SR) Tablets

Biguanide Oral Antidiabetic Matrix (500 mg / 750 mg / 1000 mg)

Healthy Life Pharma Private Limited, alongside our specialized global marketing and export division Healthy Inc, is a premier Indian manufacturer, CDMO services provider, and wholesale exporter of advanced endocrinology, metabolic health, and antidiabetic therapeutics. We manufacture a comprehensive, internationally standardized range of Metformin Hydrochloride Sustained-Release (SR) Tablets within our WHO–GMP certified, high-capacity solid dosage manufacturing installations.

As the absolute frontline baseline agent for Type 2 Diabetes management, this formulation serves as a massive-volume strategic export to national health ministries, state hospital purchasing cooperatives, insurance networks, and international digital B2B pharmaceutical marketplaces across Africa, the CIS region, LATAM, Europe, and South-East Asia.

Product Overview

This formulation operates as an “Insulin-Sensitizing Metabolic Optimizer.” It ensures patient safety and long-term glycemic control by dampening excessive hepatic glucose production and expanding peripheral tissue responsiveness to circulating insulin without causing hypoglycemia.

• Mechanism 1 (Hepatic Gluconeogenesis Suppression): Metformin physically enters hepatocytes where it chemically activates AMP-activated protein kinase (AMPK). This activation suppresses the nuclear transcription factors required for gluconeogenesis, physically cutting down the liver’s baseline production of glucose.

• Mechanism 2 (Peripheral Insulin Sensitization): It chemically increases the translocation of GLUT-4 glucose transporter proteins to skeletal muscle and adipose cell membranes. This physically accelerates peripheral glucose uptake and utilization, reducing systemic insulin resistance.

• Mechanism 3 (Intestinal Glucose Moderation): It chemically delays the rate of gastrointestinal glucose absorption while physically increasing local glucagon-like peptide-1 ($GLP\text{-}1$) secretion, smoothing out postprandial (post-meal) blood sugar spikes.

Product Composition & Portfolio Range

We manufacture Metformin SR in the full spectrum of internationally recognized therapeutic strengths, utilizing a specialized slow-release scaffold to reduce dosing frequency to once daily.

Technical & Logistics Specifications

• HS Code: 3004.90.81 (Medicaments acting on the endocrine system / Antidiabetic drugs) or 3004.90.99 (General Category)

• CAS Number: 1115-70-4 (Metformin Hydrochloride)

• Dosage Form: Oral Solid Tablet (Sustained-Release Matrix)

• Packaging Configurations: 10 / 14 / 15 Tablets per Blister Strip packed in high-barrier Alu-Alu (Cold-Form Foil) or heavy-duty amber PVC/PVDC strips. Metformin is highly water-soluble and prone to ambient moisture absorption; our premium tropicalized packaging completely shields the tablet matrix, guaranteeing a stable 36-month shelf life in hot, humid Zone IVb export environments.

Hydrogel Multi-Particulate Matrix & Release Kinetics

                 [ GASTRIC FLUIDS INGESTION ]
                              │
                              ▼
           [ HYDROPHILIC POLYMER MATRIX HYDRATION ]
                              │
                              ▼
           [ FORMATION OF GAPPED VISCOUS HYDROGEL ]
                              │
         ┌────────────────────┴────────────────────┐
         ▼                                         ▼
 [ UNIFORM ACTIVE DRUG DIFFUSION ]     [ METFORMIN SLOW DISCHARGE ]
 Continuous 12-24 Hour Release          Eliminates Local GI Toxicity

• Advanced Gastric Retentive Hydrogel Technology: Swallowed Metformin SR tablets utilize a specialized Gellan/HPMC Hydrophilic Polymer Network. Upon hitting gastric fluids, the polymers hydrate and expand into a thick, viscous gel layer. The trapped active drug molecules then chemically diffuse across this physical hydrogel boundary at a uniform, continuous rate over 12 to 24 hours.

• Gastrointestinal Tolerance Optimization: Because the drug is released slowly into the intestine rather than dumping all at once, it physically eliminates high localized mucosal irritation. This drastically reduces common complaints like nausea, bloating, and osmotic diarrhea, maximizing patient adherence.

• In-Vitro Dissolution Profiling: Every single production batch physically undergoes rigid Automated Multi-pH Dissolution Profiling, chemically validating that our sustained-release rates precisely match the bioequivalence curves and release kinetics of global innovator standards (such as Glucophage SR / Extended-Release).

Primary Indications

• Endocrinology: First-line, foundational treatment of Type 2 Diabetes Mellitus in adults and adolescents, both as monotherapy and as an adjunctive partner in combination oral regimens.

• Metabolic Syndrome & Gynecology: Off-label clinical management of Polycystic Ovary Syndrome (PCOS) to improve insulin sensitivity, reduce hyperandrogenism, and restore normal ovulatory cycles.

Usage Instructions

• The Crushing Mandate: Metformin SR tablets must be swallowed physically whole with a glass of water. Never chew, split, crush, or dissolve the tablet core. Mechanically breaking the tablet completely destroys the hydrogel barrier, chemically causing immediate dumping of the entire high-dose payload (dose-dumping), which increases gastrointestinal toxicity.

• The Post-Meal Window: Doses should be taken physically once daily with the evening meal. Administering the drug alongside food physically delays gastric emptying and matches the sustained-release kinetic curve perfectly with post-meal glucose absorption.

• The Inert Shell Pinhole Note: Advise clinical and pharmacy networks to reassure patients that the non-biodegradable polymer matrix shell may occasionally pass through the gastrointestinal tract physically intact and appear in the stool. This is anatomically normal; the active chemical has been completely leached out and absorbed.

Safety Warning: POTENT FIRST-LINE ANTIDIABETIC THERAPEUTIC. For Professional Medical Supervision Only. Lactic Acidosis Risk: Accumulation may cause rare but life-threatening Lactic Acidosis; monitor physical markers if symptoms like deep hyperventilation, severe muscle cramps, malaise, or somnolence occur. Renal Function Guideline: Because Metformin is cleared unchanged via the kidneys, checking the patient’s estimated Glomerular Filtration Rate ($eGFR$) is physically mandatory before and during long-term therapy. Contraindications: Absolute contraindications in patients presenting with severe renal impairment ($eGFR$ less than 30 mL/min/1.73m²), acute metabolic acidosis (including diabetic ketoacidosis), severe hepatic insufficiency, acute alcoholism, or dehydration.

Global CDMO Services & Wholesale Supply Chain

Healthy Life Pharma Private Limited and Healthy Inc provide complete, internationally validated Third-Party Contract Manufacturing (CDMO Services) and bulk private-label export supply for the entire Metformin SR dosage spectrum. Whether you are executing a high-volume multi-year contract for an African National Diabetes Control Tender, supplying a state pharmacy distributor across the CIS region, or maintaining active inventory listings on an international digital B2B Pharmaceutical Marketplace across Southeast Asia or LATAM, we deliver all required compliance documentation (WHO-GMP Certificate, Certificates of Pharmaceutical Product – COPP, Certificates of Analysis – COA, Stability Testing Matrix Sheets, and Complete CTD Format Dossier sets) for seamless customs clearance.

Commercial & Bulk Procurement Inquiries:

• Corporate Head Office: Mumbai, Maharashtra, India

• Primary Manufacturing Base: Boisar, Maharashtra, India

• WhatsApp / Direct Call: +91 7710003340

• Corporate Email: info@healthyinc.co.in